Candel Therapeutics Stock Probability of Future Stock Price Finishing Under 0.01

CADL Stock  USD 6.60  0.44  7.14%   
Candel Therapeutics' future price is the expected price of Candel Therapeutics instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Candel Therapeutics performance during a given time horizon utilizing its historical volatility. Check out Candel Therapeutics Backtesting, Candel Therapeutics Valuation, Candel Therapeutics Correlation, Candel Therapeutics Hype Analysis, Candel Therapeutics Volatility, Candel Therapeutics History as well as Candel Therapeutics Performance.
For more information on how to buy Candel Stock please use our How to buy in Candel Stock guide.
  
Please specify Candel Therapeutics' target price for which you would like Candel Therapeutics odds to be computed.

Candel Therapeutics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Candel Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Candel Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Candel Therapeutics had very high historical volatility over the last 90 days
Candel Therapeutics has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 31 K. Net Loss for the year was (37.94 M) with loss before overhead, payroll, taxes, and interest of (20.66 M).
Candel Therapeutics currently holds about 86.78 M in cash with (34.24 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.0.
Candel Therapeutics has a poor financial position based on the latest SEC disclosures
Roughly 30.0% of the company shares are held by company insiders

Candel Therapeutics Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Candel Stock often depends not only on the future outlook of the current and potential Candel Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Candel Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding28.9 M
Cash And Short Term Investments35.4 M

Candel Therapeutics Technical Analysis

Candel Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Candel Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Candel Therapeutics. In general, you should focus on analyzing Candel Stock price patterns and their correlations with different microeconomic environments and drivers.

Candel Therapeutics Predictive Forecast Models

Candel Therapeutics' time-series forecasting models is one of many Candel Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Candel Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Candel Therapeutics

Checking the ongoing alerts about Candel Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Candel Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Candel Therapeutics had very high historical volatility over the last 90 days
Candel Therapeutics has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 31 K. Net Loss for the year was (37.94 M) with loss before overhead, payroll, taxes, and interest of (20.66 M).
Candel Therapeutics currently holds about 86.78 M in cash with (34.24 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.0.
Candel Therapeutics has a poor financial position based on the latest SEC disclosures
Roughly 30.0% of the company shares are held by company insiders
When determining whether Candel Therapeutics is a strong investment it is important to analyze Candel Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Candel Therapeutics' future performance. For an informed investment choice regarding Candel Stock, refer to the following important reports:
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Candel Therapeutics. If investors know Candel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Candel Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Candel Therapeutics is measured differently than its book value, which is the value of Candel that is recorded on the company's balance sheet. Investors also form their own opinion of Candel Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Candel Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Candel Therapeutics' market value can be influenced by many factors that don't directly affect Candel Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Candel Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Candel Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Candel Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.